Evexia Lifecare Share Price Target From 2025 to 2030: Evexia Lifecare is the new face of the healthcare and pharmaceutical industry. Concentrating on quality health care solutions, this company is steadily and gradually trying to make its space in the market. In this paper, we will present a deep analysis of the financial data and recent developments, along with the projected Evexia Lifecare Share Price Target From 2025 to 2030. In so doing, we will answer some frequently asked questions, along with all relevant information about the company.
Company Overview
Evexia Lifecare Limited is a pharmaceutical and healthcare company focused on the manufacture and distribution of pharmaceutical products. Quality-sensitive, the company has diversified its product portfolio under different segments across various therapeutic categories. Keen on innovation and sustainability, Evexia Lifecare has always been committed to making healthcare accessible for all.
Key Financial Metrics For Evexia Lifecare Share Price
- Market Capitalization: ₹578.22 Crores
- P/E Ratio: 47.60
- 52-Week High: ₹4.40
- 52-Week Low: ₹1.94
- Current Share Price: ₹3.09
The Evexia Lifecare Share Price in the last one year has increased by 35.53%, which signifies better market performance along with the increasing confidence of investors.
Shareholding Pattern For Evexia Lifecare Share Price
- Retail and Others: 92.47%
- Promoters: 5.87%
- FII/FPI: 1.49%
- Other Domestic Institutions: 0.13%
- Mutual Funds: 0.04%
Shareholding Changes For Evexia Lifecare Share Price
- Promoters: from 6.29% to 5.87%.
- Promoters’ Pledged Shares: All pledges are cleared.
- Foreign Institutional Investors (FII/FPI): Holding has increased to 1.49% from 1.03%. Number of FII/FPI has increased from 5 to 6.
- Mutual Funds: Holding of Mutual Funds at the end is stagnant at 0.04%. Three schemes from Mutual Fund invest in this company.
- Institutional Investors: Holding in totality increases from 1.20% to 1.66%
Evexia Lifecare Share Price Targets (2025-2030)
Based on the market trends and growth prospects with financials, share price targets for this company are estimated based on the performance of the industry.
| Year | Share Price Target |
| 2025 | ₹5 |
| 2026 | ₹8 |
| 2027 | ₹11 |
| 2028 | ₹14 |
| 2029 | ₹17 |
| 2030 | ₹20 |
2025: Evexia Lifecare Share Price Target ₹5
Moderate growth can be expected, and by 2025, the price target is expected to be at ₹5. This is because the growth shows higher investor confidence and improved financial performance.
2026: Evexia Lifecare Share Price Target ₹8
By 2026, sales as well as strategic partnership shall increase for Evexia Lifecare. The shares would be expected at the level of ₹8. Later, growing access towards newer markets is going to bring much-needed boom in growth.
2027: Evexia Lifecare Share Price Target ₹11
The stock is anticipated to move towards ₹11 by 2027, due to the company now being more focused towards R&D, innovation, improving market penetration, and expansion in customer base.
2028: Evexia Lifecare Share Price Target ₹14
With continuous revenues growth and operational expansion, the share price will increase towards ₹14 by 2028. The growing interest of the investor and financials will likely support the hike.
2029: Evexia Lifecare Share Price Target ₹17
By 2029, the company would continue consolidating further its market positions and would reach to the target price of ₹17. The growth drivers will be in the form of increased profitability with efficient usage of resources.
2030: Evexia Lifecare Share Price Target ₹20
The target for the period 2030 would be the long-term at ₹20. By this time, Evexia Lifecare should be able to touch all the intended growth it desires for its span, which was built into its sustainable performance with expansion in markets.
Growth Drivers of Evexia Lifecare Share Price
- Geographic Footprints Expansion: The company targets the expansion of geographic footprints as well as catering to different therapeutic segments.
- Research and development investment: This in the process enables Evexia Lifecare to maintain its competitive advantage through the products and innovations that come forth from the company.
- Sound Retail Participation: At 92.47%, retail investment in the firm ensures that there is optimism over the markets to offer support towards the company.
- Growth in FII/FPI: From 1.03% to 1.49%, the growth indicates that the foreign institutional investors’ holding is picking up on the company.
- Operational Efficiency: Release of pledged shares and improvement in financials is a reflection of the company following better management practices and efficiency in operations.
Strengths and Challenges For Evexia Lifecare Share Price
Strengths For Evexia Lifecare Share Price
- Consistent growth in share price in last year (35.53 percent).
- Strong participation from retail investors to make the market stable.
- Surging FII/FPI and institutional investor interest.
- Focus on innovation and addition of new products to the portfolio.
Challenges For Evexia Lifecare Share Price
- Promoter holding stands at a relatively lower level of 5.87%. P/E of the company is pegged at 47.60.
- Dividend yield is on the lower side. Thus, it cannot be said as an attractive source for income-oriented investors.
FAQs For Evexia Lifecare Share Price
Q1. Evexia Lifecare share price is what it will touch in 2025?
The Evexia Lifecare Share Price for the year 2025 is witnessed at ₹5 as the momentum of growth being sustained through operational efficiency and market expansion.
2. The promoters’ holding had eased off in the last quarter. Why?
The promoters had reduced their holding from 6.29% to 5.87%. Probably to boost the cash and rebalance the portfolio, but did release all equity shares pledged showing improvement in discipline in finances.
3. Why has there been high participation from retail investment in Evexia Lifecare?
92.47% of the shareholding with the retail investors is because the price of the stocks is low along with tremendous scopes of growths, and sentiment of the markets are in its favor for healthcare stock.
4. How had FII / FPI had recently changed in participation?
FII / FPI holdings have increased from 1.03% to 1.49%. Number of foreign institutional investor had increased by 5 from 6.This shows, more international involvement with the group.
5. Is Evexia Lifecare a long term investment opportunity?
Evexia Lifecare is a good long-term investment because of its expected growth prospects and innovation focus as well as increased investor confidence. However, one should be concerned about the attached risks with a high P/E ratio along with limited promoter holding.
6. What is 2030 Evexia Lifecare Share Price expectation?
Evexia Lifecare Share Price target for long term on 2030 is ₹20 through operational efficiency and market expansion by innovation
7. Why no dividend yield of the company?
May be investing it again in activities relating to R and D, geographical expansion etc without distributing anything for the dividends in the form of returns on that investment for its shareholders
8. Risks involved while investment in Evexia Lifecare.
The key risks include high valuation and a lower P/E ratio of 47.60, promoter holding is low, and there is no dividend payout. All these risks have to be considered by investors before it is invested in.
Evexia Lifecare is a growth player in the space of healthcare and pharmaceuticals. Evexia Lifecare Share Price targets from 2025 to 2030 are stable; the company has been working toward operational excellence, innovation, and market expansion. Even with strong support from retail and institutional investors, high valuations and low promoter holdings cannot be ignored.
For a long-term growth investor with a corporate interest to invest in health, Evexia Lifecare is a bright investment opportunity that, however, should be subjected to due diligence, and proper assessment of the given risk.
